Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936178 · ClinicalTrials.gov registry record · Phase 1
A Study of NB003 in Patients With Advanced Malignancies
A Phase 1 study of Advanced Solid Tumor, sponsored by Ningbo Newbay Technology Development Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 258
- Enrollment target
- 20
- Study locations
NCT04936178: Completed Phase 1 study of Advanced Solid Tumor, sponsored by Ningbo Newbay Technology Development Co..
NCT04936178 is a Phase 1 study of Advanced Solid Tumor that has completed, run by Ningbo Newbay Technology Development Co.. The registered enrollment target is 258 participants, above the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (34% higher). The trial reports 20 study locations across 18 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04936178, a Phase 1 study of Advanced Solid Tumor, has completed, sponsored by Ningbo Newbay Technology Development Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 258 participants
- Enrollment target
- 20
- Study locations
Study Summary
This a A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB003 in Subjects with Advanced Malignancies
Primary Outcome
Dose Escalation Phase：Dose-limiting toxicities will be reviewed as a subset of adverse events that occur within the first 28 days of dosing and meet protocol-specified criteria.
Conditions Studied
Interventions
- DRUG NB003 tablets
Study Locations (20)
Beijing Municipality
- Beijing Cancer Hospital - Beijing
- Peking University People's Hospital - Beijing
Guandong
- Sun Yat-sen University Cancer Center - Guangzhou
- The First Affiliated Hospital of Sun Yat-sen University - Guangzhou
California
- Standford University - Stanford
Florida
- Mayo Clinic - Jacksonville
Massachusetts
- Dana-Farber Cancer Institute - Boston
New York
- Memorial Sloan Kettering Cancer Center - Long Island City
Oregon
- Oregon Health & Science University (OHSU) - Portland
Texas
- U T MD Anderson Cancer Center Investigational Pharmacy Services - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2025-08-01 |
| Phase | Phase 1 |
What the finished NCT04936178 record still lists
NCT04936178 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, above the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (34% higher).
The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which NB003 tablets is the first listed.
NCT04936178 names 20 study sites across 18 states, led by Beijing Municipality, Guandong, California.
Frequently Asked Questions
What is clinical trial NCT04936178 about?
NCT04936178 is a clinical study titled "A Study of NB003 in Patients With Advanced Malignancies". This a A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB003 in Subjects with Advanced Malignancies
What is the current status of trial NCT04936178?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 258 participants. The study started on 2021-08-06. Estimated completion is 2025-08-01.
What conditions does trial NCT04936178 study?
This clinical trial studies the following conditions: Advanced Solid Tumor.
What interventions are being tested in trial NCT04936178?
The interventions under investigation include: NB003 tablets (DRUG).
Who is sponsoring clinical trial NCT04936178?
This trial is sponsored by Ningbo Newbay Technology Development Co., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04936178 being conducted?
This trial has 20 study locations across California, Florida, Massachusetts, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04936178's enrollment target sits among peer trials
258 43rd of 189 higher than 146 of 189 other Advanced Solid Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Solid Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI